MergerLinks Daily Review
MergerLinks
Join a community of 250,000+ M&A professionals. Expand your network and discover new business opportunities.
Welcome to MergerLinks Daily Review.?Sign up here ?to get the full round up of your daily dose of blue-chip M&A news directly to your inbox.
AbbVie eyes selling at least $13bn of bonds to fund M&A.?
TPG in talks on €4.5bn deal for Permira’s Alter Domus. (Financial Sponsors)
You can access today’s complete newsletter?here .
Scroll down for more…
Democrat Congresswoman Maxine Waters said she was "deeply opposed" to One Capital Financial 's $35.3bn planned acquisition of 发现金融服务公司 and called on banking regulators to block the deal, Reuters reported.?
"This merger represents yet another struggle to rein in the economic power of the megabanks, and ensure that our financial system is designed to serve consumers, small businesses and communities across America, not Wall Street,"?Maxine Waters,?Democrat Congresswoman.?
Discover Financial is advised by 摩根士丹利 , PJT Partners , and Sullivan & Cromwell LLP (led by H. Rodgin Cohen). Capital One Financial is advised by Centerview Partners and Wachtell, Lipton, Rosen & Katz (led by Matthew Guest , Edward Herlihy, and Brandon Price).
Chord Energy , a company engaged in hydrocarbon exploration and hydraulic fracturing, agreed to merge with Enerplus , an independent oil and gas producer, in a $11bn deal.
"This combination further strengthens our Williston Basin position and represents a compelling opportunity for both companies' shareholders. Enerplus' Williston Basin position brings high-quality inventory, and we are excited to leverage best practices from both companies to create a stronger, more efficient entity. The combined company is expected to benefit from improving returns, capital efficiency, low-cost inventory, and a peer-leading balance sheet, all of which support sustainable free cash flow generation and meaningful shareholder returns," Danny Brown, Chord Energy President and CEO.
Enerplus is advised by BMO Capital Markets , CIBC , Evercore , RBC Capital Markets , Blake, Cassels & Graydon LLP and Latham & Watkins . Chord Energy is advised by 花旗 , J.P. 摩根 , 富国银行 , Goodmans LLP , Vinson & Elkins (led by David Palmer Oelman ) and Wachtell, Lipton, Rosen & Katz (led by Dan Neff and Zachary Podolsky).
阿斯利康 , a pharmaceutical company, completed the acquisition of Gracell Biotechnologies , a global clinical-stage biopharmaceutical company, for $1.2bn.
“We look forward to working with AstraZeneca to accelerate our shared goal of bringing transformative cell therapies to more patients living with debilitating diseases. By combining our expertise and resources, we can unlock new ways to harness the Gracell FasTCAR manufacturing platform, which we believe has the potential to optimise the therapeutic profile of engineered T cells, to pioneer the next generation of autologous cell therapies,” William Cao, Gracell Biotechnologies Founder, Chairman and CEO.
Gracell was advised by Centerview Partners (led by E. Eric Tokat ), 锦天城律师事务所 , Cooley LLP (led by Rama Padmanabhan ), Harneys and ICR Healthcare U.S. (led by Stephanie Carrington ). Centerview was advised by Gibson Dunn (led by Andrew Kaplan ). AstraZeneca was advised by 富而德律师事务所 (led by Zheng (Jonathan) Zhou and Sebastian Fain ), Maples Group and RuiMin.
AbbVie eyes selling at least $13bn of bonds to fund M&A.
Pharmaceutical giant AbbVie is looking to sell at least $13bn of corporate bonds to help fund its acquisitions of ImmunoGen and Cerevel Therapeutics , Bloomberg reported.
The sale is expected to be announced as soon as February 22, following fixed-income investor calls on February 21. The size of the offering is subject to change, and will be determined on the day of the sale.
TPG in talks on €4.5bn deal for Permira’s Alter Domus. (FS)
TPG has emerged as the highest bidder for Alter Domus , the fund administration company backed by Permira , in what’s set to be one of the biggest European private equity deals this year, Bloomberg reported.
The buyout firm is competing with rival suitors Hellman & Friedman and Cinven to acquire the business. A transaction could value Alter Domus at about €4.5bn ($4.9bn).
Interested to find more??Sign up here ?to get full round up of your daily dose of blue-chip M&A news directly to your inbox.
You can access today’s complete newsletter here .